Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Data From ACS NSQIP on CRS-HIPEC

Data From ACS NSQIP on CRS-HIPEC Research Original Investigation Surgical Outcomes of HIPEC Invited Commentary Can They Cool Off the Controversies? Amanda K. Arrington, MD; Joseph Kim, MD Jafari et al should be congratulated on their timely report of histology. Furthermore, the consideration of CRS-HIPEC must the short-term morbidity and mortality of cytoreductive sur- involve a careful measurement of the extent of disease that can gery (CRS) and hyperthermic intraperitoneal chemotherapy be reasonably managed by this radical intervention. Re- (HIPEC) in this issue of JAMA Surgery. Their data highlight the cently, experts in CRS-HIPEC formed the Peritoneal Surface Ma- low mortality and accept- lignancy Group and outlined patient eligibility criteria: peri- able morbidity from Ameri- toneal cancer index score (ie, a measurement of tumor burden) Related article page 170 can College of Surgeons (ACS) of less than 20, absence of metastatic disease to the liver, and National Surgical Quality Improvement Program (NSQIP) hos- absence of significant medical comorbidities. Unfortu- pitals. Moreover, these outcomes are important because they nately, peritoneal cancer index scores are not collected by the relate the experience of a broad spectrum of centers perform- ACS NSQIP. ing this radical intervention. However, what the study lacks Methodology (eg, length of perfusion and type http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Surgery American Medical Association

Data From ACS NSQIP on CRS-HIPEC

JAMA Surgery , Volume 149 (2) – Feb 1, 2014

Data From ACS NSQIP on CRS-HIPEC

Abstract

Research Original Investigation Surgical Outcomes of HIPEC Invited Commentary Can They Cool Off the Controversies? Amanda K. Arrington, MD; Joseph Kim, MD Jafari et al should be congratulated on their timely report of histology. Furthermore, the consideration of CRS-HIPEC must the short-term morbidity and mortality of cytoreductive sur- involve a careful measurement of the extent of disease that can gery (CRS) and hyperthermic intraperitoneal chemotherapy be reasonably managed by this radical...
Loading next page...
 
/lp/american-medical-association/data-from-acs-nsqip-on-crs-hipec-yLXRBZv0FT
Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6254
eISSN
2168-6262
DOI
10.1001/jamasurg.2013.3665
pmid
24352564
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation Surgical Outcomes of HIPEC Invited Commentary Can They Cool Off the Controversies? Amanda K. Arrington, MD; Joseph Kim, MD Jafari et al should be congratulated on their timely report of histology. Furthermore, the consideration of CRS-HIPEC must the short-term morbidity and mortality of cytoreductive sur- involve a careful measurement of the extent of disease that can gery (CRS) and hyperthermic intraperitoneal chemotherapy be reasonably managed by this radical intervention. Re- (HIPEC) in this issue of JAMA Surgery. Their data highlight the cently, experts in CRS-HIPEC formed the Peritoneal Surface Ma- low mortality and accept- lignancy Group and outlined patient eligibility criteria: peri- able morbidity from Ameri- toneal cancer index score (ie, a measurement of tumor burden) Related article page 170 can College of Surgeons (ACS) of less than 20, absence of metastatic disease to the liver, and National Surgical Quality Improvement Program (NSQIP) hos- absence of significant medical comorbidities. Unfortu- pitals. Moreover, these outcomes are important because they nately, peritoneal cancer index scores are not collected by the relate the experience of a broad spectrum of centers perform- ACS NSQIP. ing this radical intervention. However, what the study lacks Methodology (eg, length of perfusion and type

Journal

JAMA SurgeryAmerican Medical Association

Published: Feb 1, 2014

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month